• Home
  • Archive by category "ypldundf"

An experimental AI system can predict when pancreatic cysts will become cancerous

first_img Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. First 30 days free. GET STARTED Log In | Learn More About the Author Reprints [email protected] National Technology Correspondent Casey covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. He is the co-author of the newsletter STAT Health Tech. Pancreatic cancer often kills people because they are diagnosed too late, after their tumors have spread. Other patients may die following the removal of harmless cysts that appear threatening amid a fog of imaging data and other clinical information.But a new artificial intelligence system unveiled Wednesday by doctors at Johns Hopkins offers to provide a clearer picture for patients: In testing, it displayed a superhuman ability to differentiate harmful lesions from ones that pose no threat at all. @caseymross By Casey Ross July 17, 2019 Reprints STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What is it?center_img GET STARTED A cluster of pancreatic cancer cells. Anne Weston/Francis Crick Institute/Wellcome Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. An experimental AI system can predict when pancreatic cysts will become cancerous What’s included? Tags Artificial Intelligencecancerresearch Health Tech Casey Rosslast_img read more

With a new guide to tapering opioids, federal health officials seek a balanced approach to prescribing

first_img Related: The new guide marks the government’s attempt to strike a balance between reducing the amount of opioids prescribed and ensuring patients aren’t left behind. It also reflects concerns that prescribing guidelines released by the government in 2016 were misapplied and contributed to inappropriate tapers.On a call with reporters Wednesday, Dr. Brett Giroir, an assistant secretary at the Department of Health and Human Services, said it was possible to address the roots of the addiction crisis while helping people receive the medications they need.advertisement ERIC BARADAT/AFP/Getty Images [email protected]ws.com Tags addictiongovernment agenciesopioidspolicy “It is a false choice to say we can only limit opioid use disorder, or addiction, or have pain control,” he said. About the Author Reprints Andrew Joseph By Andrew Joseph Oct. 10, 2019 Reprints Newsletters Sign up for Morning Rounds Your daily dose of news in health and medicine. Please enter a valid email address. HealthWith a new guide to tapering opioids, federal health officials seek a balanced approach to prescribing Privacy Policy Overall, the guide casts the decision to taper as an individualized one that prescribers and patients should reach together. Tapers may need to go slowly and their effects should be reviewed throughout the process. Patients need to have their concerns addressed, the guide stresses. It even suggests clinicians reiterate to patients that, “I’ll stick by you through this,” and to offer other forms of support.Successful tapers to lower dosages can lead to improvements in sleep, mood, and overall daily function without leading to a resurgence of pain, according to the guide. But it also describes the risks of rapid tapering on the first of its six pages. It warns that doing so can induce withdrawal symptoms and recommends that abrupt dose reductions only happen when there are concerns about impending overdoses or other life-threatening issues. It also provides examples of when patients and prescribers should consider tapering, including when the drugs appear not to be working for pain control, or when the patient has side effects or starts taking certain other types of medications, including benzodiazepines.On the call with reporters, Dr. Deborah Dowell of the Centers for Disease Control and Prevention said there are not specific targets that dose reductions should try to hit. Instead, patients and clinicians should find doses where the benefits of opioid use outweigh the risks.“Tapering success does not mean getting down to zero or to any particular dose,” Dowell said.While experts widely agree that overprescribing contributed to the opioid addiction crisis, there’s been an ongoing debate about how insistently to pursue tapers for chronic pain patients. Many who have been on opioids for years have grown dependent on the drugs, and it can be difficult for them to come off the medications. It can also be hard to distinguish whether tapering is leading to a return of pain or temporary symptoms of withdrawal.While some experts have preached caution — in some cases advocating leaving patients at high doses if tapering could throw off their lives — others argue that leaving patients on these doses for long periods is bad medicine. Higher dosages of opioids are associated with overdose risk, and there is evidence that chronic opioid use can leave people more sensitive to pain and contribute to anxiety and depression. Pelosi’s drug pricing plan could wipe out some key funding for low-income hospitals @DrewQJoseph Federal health officials on Thursday released a guide for clinicians who are considering tapering patients’ opioid prescriptions, highlighting the benefits of safe reductions in dosages while warning against abrupt drops for people who have been on the drugs for long periods.The recommendations come amid concerns that some chronic pain patients’ dosages have been unsafely pulled back and that providers have sometimes abandoned patients. Some experts and advocates have warned that overly aggressive reductions or forced cutbacks have led some patients who are dependent on the drugs to seek out illicit sources of opioids or consider suicide.The anxiety around prescribing built in response to the opioid crisis, which drove more than 47,000 fatal overdoses in 2017 alone. The crisis was caused in part by some clinicians overprescribing the drugs, leading to cases of addiction in patients and a source of pills that were diverted. Prescribing levels have dropped since 2012, and some advocates have warned that the fear around opioids has left some patients unable to get them.advertisement General Assignment Reporter Andrew covers a range of topics, from addiction to public health to genetics. Leave this field empty if you’re human: Much of the debate has focused on a set of 2016 prescribing recommendations from the CDC. The guidelines were a measured set of proposals, including that clinicians treating chronic pain try other therapies before opioids and prescribe only the lowest effective dose and duration of the drugs. The CDC suggested that prescribers “work with patients to taper opioid to lower dosages or to taper and discontinue opioids” in cases where the harms of taking the drugs outweigh the benefits.But after the guidelines came out, insurers, pharmacies, states, and law enforcement agencies started cracking down on high prescribing, often pointing to the guidelines as the source of their policies. Clinicians grew even more nervous about treating chronic pain patients, advocates said, and sometimes dismissed their patients.Earlier this year, the authors of the CDC guidelines wrote in a follow-up paper that their recommendations had been misapplied. They said that some agencies and companies used the guidelines incorrectly to justify an “inflexible application of recommended dosage and duration thresholds and policies that encourage hard limits and abrupt tapering of drugs dosages.”Dowell (who is one of the authors of the CDC guidelines), Giroir, and Dr. Wilson Compton of the National Institute on Drug Abuse also wrote a piece in JAMA Thursday describing the tapering guide. In it, they write that “clinicians have a responsibility to provide care for or arrange for management of patients’ pain and should not abandon patients.”They add: “For patients who are unable or unwilling to taper and who continue receiving high-dose or otherwise high-risk opioid regimens … close monitoring and mitigation of overdose risk are recommended.”last_img read more

What value? High prices for dozens of cancer drugs aren’t tied to better clinical benefits

first_img By Ed Silverman April 30, 2020 Reprints STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. As payers increasingly demand good value for medicines, a new analysis found that costs for dozens of cancer drugs in the U.S. were 2.3 times higher than in four wealthy European nations. And at the same time, there was generally no association between the clinical benefits of the drugs and the monthly treatment costs in most of the countries.In other words, pricing was not aligned with the actual benefits, according to the study, which was published in The Lancet Oncology. And the findings led the researchers to conclude that existing frameworks for assessing value could not only help identify cancer medicines with small or uncertain benefits, but might also be useful tools for negotiating prices with manufacturers. Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. First 30 days free. GET STARTED Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. [email protected] Tags cancerdrug pricingSTAT+ @Pharmalot Chemotherapy drugs are administered to a patient. In a new study, researchers examined whether higher prices on cancer drugs were correlated with higher clinical benefit. Gerry Broome/AP Ed Silvermancenter_img What value? High prices for dozens of cancer drugs aren’t tied to better clinical benefits What is it? Log In | Learn More What’s included? About the Author Reprints Pharmalot Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. GET STARTEDlast_img read more

A national Covid-19 vaccine confidence project: job No. 1 for President-elect Biden

first_img President-elect Joe Biden JIM WATSON/AFP via Getty Images Privacy Policy David Beier linkedin.com/in/david-bluestone/ A national confidence-building plan cannot be monolithic. It must be tailored to different segments of the American public, each with different reasons for skepticism, different levels of trust in different people and institutions, and different attitudes and behaviors toward how they protect themselves today. Getting back to normal requires getting this plan right. Getting it wrong puts our recovery — and people’s lives — at risk. [email protected] Leave this field empty if you’re human: By Inauguration Day, the wait-and-see majority may no longer be sitting on the fence. In the time between the election and the inauguration, politics will remain omnipresent and rhetoric between the outgoing and incoming president over taking credit for the vaccine and distribution effort may even sharpen. If politics continues to infiltrate the vaccine conversation, it will further erode confidence in a vaccine, putting our national recovery at risk.Our country needs a national vaccine confidence project. If vaccines are to pave the road back to normal, this project serves as the road map for them.During the Oct. 30 meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, a vague project on vaccine confidence was presented. It didn’t go far enough.A vaccine confidence project should be created and led by the best public health experts from academia with full support and collaboration from the private sector. Participants should be drawn from local, state, federal, and international levels. A vaccine confidence project must be nonpolitical if it has any hope of persuading the wait-and-see group to get the vaccine in a timely way. It fails if it is perceived as a political effort, such as a presidential directive, resulting from a political event like the election.Instead, this effort, which requires a significant private-sector component, must focus on the safety and efficacy of the vaccine as well as on the fairness and equity of its distribution.A vaccine confidence project should be based on sound principles of public health communication:Rely on sound science and engage in evidence-based decision-making.Be honest about what is known and not known.Protect people from harm.Assure full and fair access to vaccines.Allocate and prioritize vaccine supplies and distribution based on transparency and equity, and account for the need to protect health workers, essential workers, and vulnerable populations.Who is the audience for this project? The various segments of the wait-and-see majority who lack confidence in Covid-19 vaccines but who are open to them. The goal is to maintain that openness and reduce the time before they are willing to get vaccinated.Doing that requires addressing the greatest sources of hesitation cited in the ClearPath poll, all of which are interrelated: the speed of the process, potential side effects from the vaccine, and politicization of the process. To better understand Americans’ attitudes toward Covid-19 vaccines, ClearPath Strategies, the company two of us (Bluestone and Garrett) founded, recently conducted a nationally representative poll of 1,015 U.S. adults. Instead of showing a red vs. blue divide, it showed that the collective American response to the pandemic has a bell curve distribution. At one extreme, 16% would do nothing and simply want Covid-19 to run its course. At the other extreme, 19% believe their states must employ radical measures like lockdowns. Most Americans, though — 65% — are in the middle, advocating some combination of targeted interventions, personal behavior change, and sheltering in place.advertisement Public opinion research provides clear guidance on addressing these concerns, such as educating people on the rigorous and transparent trials that put science first, involve tens of thousands of volunteers — including people who “look like me” — and benefit from industry-wide collaboration across pharmaceutical companies.This effort must heavily message key groups of skeptics to assuage concerns and persuade them be vaccinated. Three groups the survey identified are Black Americans, individuals who have not attended college, and young adults under age 30. These populations respond very differently to key influencers. For example, Black Americans trust Dr. Anthony Fauci more than their places of worship or federal government agencies. For non-college graduates and especially for 18-to 29-year-olds, local influencers as well as institutions like the FDA, CDC, and Mayo Clinic are all more trusted than Fauci, who actually ranks last for the under-30 crowd.The vaccine confidence project will require a multichannel communications program that features these entities and individuals with the highest trust levels according to research for each of these groups, from the grassroots (personal doctors, pharmacists, church leaders, and the like) to advertising featuring national figures and agencies (such as Fauci, the FDA, and medical experts).Such a project must operate in the context where demand for the vaccine will not be a flip of a switch, but will be a cascade, with ebbs and surges. As more people get vaccinated against Covid-19 and the pandemic becomes less severe, and as consistency in communication breeds confidence, we will see waves of people crossing the invisible threshold to embrace a Covid-19 vaccine.The road to a new normal will have twists, detours, and setbacks. The vaccine trials will have successes and failures. Medical experts will learn and update protocols. On this journey, all of us will still need to apply the best tools and practices we have to date, such as social distancing, wearing masks, and washing hands. We will also need better treatments and enough medical personnel, personal protective equipment, and hospital beds.No setback would be greater to the country’s efforts to control the devastating coronavirus pandemic than Americans’ broad refusal to take a safe and effective vaccine. That means no effort can be more important than improving their confidence that vaccines will be safe, will be effective, and will put us on the smoothest road to a new normal.David Bluestone is a founding partner of ClearPath Strategies, a public opinion research and strategy firm. John Garrett is a founding partner of ClearPath Strategies who specializes in the firm’s public health and pharmaceutical research. David Beier is a managing director of Bay City Capital, a San Francisco venture firm, and former chief domestic policy adviser to Vice President Al Gore. Newsletters Sign up for Daily Recap A roundup of STAT’s top stories of the day. Please enter a valid email address. @baycitycapital Related: STAT-Harris Poll: The share of Americans interested in getting Covid-19 vaccine as soon as possible is dropping center_img Related: Biden’s ready to start his pandemic response immediately  First OpinionA national Covid-19 vaccine confidence project: job No. 1 for President-elect Biden David Bluestone [email protected] President-elect Joe Biden faces many grave challenges. The one we believe to be paramount is that the lack of coherent, national leadership to date in the face of the Covid-19 pandemic has left Americans to respond to it in their own ways instead of responding together in a logical, coordinated fashion.By letting individuals’ decisions revert to America’s “red versus blue” mold, we imperil our strongest national strategic asset in this fight: safe and effective vaccines against Covid-19.Unless we increase people’s confidence in Covid-19 vaccines, we will fail to reach the protection that comes from community-wide immunity. What’s needed is a national plan to build confidence that is led by science and experts, heavily rooted in the community and grassroots, and not an extension of political campaigns or tempted by the false hope of a national celebrity campaign or public service ad campaigns offering special vaccine deals to Santa Claus performers.advertisement About the Authors Reprints John Garrett The poll showed that 67% of Americans believe that getting back to some form of normal requires safe and effective vaccines. Yet public confidence in Covid-19 vaccines is low. Only 38% of respondents said they would be willing to take a vaccine within the first three months after it became available, while 33% said they would be willing to take it after three months and 29% said they would wait at least one year. These results are reflected in other national surveys, such as those conducted by the Pew Research Center and Gallup, showing a troubling trend toward lower confidence in Covid-19 vaccines.So most Americans are in a wait-and-see mode regarding Covid-19 vaccines. They lack confidence in the speed of vaccine development and the diligence of the clinical trials. For some, the risk of the pandemic is not enough to warrant taking what they view as a rushed — and therefore risky — vaccine. Others have faith in vaccines and the scientists producing them, but question whether the speed of development is influenced by political motivations at the expense of scientific rigor.Fortunately, these wait-and-see Americans are persuadable. Their confidence in the vaccine and the process can be boosted. They are receptive to messages that offer details on the rigor of clinical trials processes and about how Covid-19 vaccines will help protect everyone and get us back to normal.But the time for doing this is short. By David Bluestone, John Garrett, and David Beier Nov. 8, 2020 Reprints [email protected] Tags CoronavirusVaccineslast_img read more

Deaths in Laois – Friday, February 7, 2020

first_img Bizarre situation as Ben Brennan breaks up Fianna Fáil-Fine Gael arrangement to take Graiguecullen-Portarlington vice-chair role Previous articleYour full guide to all of this week’s local sports fixtures in LaoisNext articleTalking Sport: Laois v Cavan, Transfer News, Love Island splits & Laois’s greatest sports person Megan ShielMegan is currently studying English and New Media at the University of Limerick. A Raheen native, she’s happiest when talking sport, especially soccer but just don’t mention the 2019 champions league final Twitter Deaths in Laois – Friday, February 7, 2020 Below are the recent deaths in Laois.Ar Dheis De go raibh a anam.Martin MooreBourne Avenue, Ashbourne, Meath / LaoisMartin, peacefully at St. Francis Hospice, Blanchardstown. Loving husband of Ann and dearest father of Grace, Sarah, Olive, John and Paul, and dear brother of Mary. Sadly missed by his family, his adored grandchildren, sons-in-law Fergal and Niall, daughters-in-law Maryellen and Emma, extended family, relatives and his many dear friends.May He Rest In PeaceReposing at Ryans Funeral Home, Ashbourne (A84CX52) from 4pm this Thursday evening with removal same evening to The Church Of The Immaculate Conception, Ashbourne arriving at 7pm. Funeral Mass on Friday morning at 10am followed by Cremation in Glasnevin Crematorium at 12.20pm. Family flowers only please. Donations, if desired, to St Francis Hospice, Blanchardstown.Kathleen Lanham (née McCarthy)Upper Sconce, Mountrath, LaoisKathleen Lanham (neé McCarthy), late of Upper Sconce, Ballyfin, Co.Laois. Died 5th February 2020, in her 95th year, surrounded by her loving family, and in the exceptional care of the matron and staff of Oakdale Nursing Home, Portarlington, predeceased by her husband Joe and her daughter Michelle-Ann. Deeply regretted by her loving sons George, Austin and Joe, daughters Mary (Finn), Breda (Culleton), Pat (Lambe) and Catherine (Sheahan), daughters-in-law, sons-in-law, sister-in-law Essie (Lanham), grandchildren, great-grandchildren, nieces, nephews, relatives, neighbours and friends.May She Rest In PeaceReposing at Burke’s Funeral Home, Mountrath this Thursday evening from 5p.m., with Funeral Prayers at 6.30p.m., followed by Removal to St. Fintan’s Church, Ballyfin, arriving at 7.30p.m.. Requiem Mass on Friday morning at 12 noon, followed by Burial in St. Fintan’s Cemetery, Ballyfin.Family Flowers only please, donations if desired to Oakdale Nursing Home Portarlington.Anne Stapleton (née Meagher)Kill, Kildare / Rathdowney, LaoisStapleton (nee Meagher) (Kill and formerly of Rathdowney, Co. Laois) – Feb. 5, 2020, (peacefully), in the wonderful care of the staff, at St. Brigid’s Hospice, The Curragh, Anne, beloved wife of Jim and dear mother of Alan and Matt; Sadly missed by her loving husband, sons, father Nick, mother Marion, brothers Nick, Doug, Graham and Greg, sisters Felicity and Jane, daughters-in-law Sarah and Lil, brothers-in-law, sisters-in-law, grandchild Ruairí, nephews, nieces, relatives and friends.Reposing at her home on Thursday from 4pm to 8pm. Removal on Friday to St. Brigid’s Church, Kill arriving for 10am Mass. Funeral immediately afterwards to Newlands Cross Crematorium. Family flowers only please. Donations, if desired, to St. Brigid’s Hospice, The Curragh. Enquiries to Murphy Brothers Funeral Directors Church Lane, Naas Ph: 045 897397.“May She Rest In Peace”Patricia Seery (née Campion)Swords, Dublin / Portlaoise, LaoisSeery (née Campion), Patricia (Swords and formerly of Portlaoise) – February 5th, 2020, (peacefully) at Beechfield Manor Nursing Home, Shankhill. Beloved wife of the late Sean; sadly missed by her loving brothers Patsy and Michael, sisters Mary (Sr. Catherine) and Nuala, nieces, nephews, grandnieces, grandnephews, relatives and friends.May she Rest In Peace.Reposing at Rock’s Funeral Home, Swords on Thursday (6th Feb.) evening from 5.30 p.m. With removal to St. Finian’s Church, River Valley arriving for 7 p.m. Funeral after 10 a.m. Mass on Friday (7th Feb.) morning followed by burial to Swords Cemetery.Ar dheis Dé go raibh a hanam dílisElizabeth FarrellHarpurs Lane, Portlaoise, LaoisFarrell (nee Molloy) Chestnut Drive, Harpurs Lane, Portlaoise, 4th Feb 2020, peacefully, surrounded by her loving family. Elizabeth, mother to the late Pascal and sister to the late Mary. Beloved wife of Frank and dearly loved mum to Michael, David, Ken and Regina. Deeply regretted by her loving family and their partners, grandchildren, great-grandchild, brother Séan, sister Georgina, daughters in law, brothers in law, sisters in law, nephews, nieces, relatives and friends.Rest in PeaceReposing at her daughter Regina’s house at Rathevan Heights on Thurday evening from 5pm with rosary at 8pm. Removal on Friday morning to arrive at SS Peter and Paul’s church for 10am requiem Mass. Interment afterwards in SS Peter and Paul’s Cemetery. House private on Friday morning, please.SEE ALSO – Deaths in Laois – Thursday, February 6, 2020 2020 U-15 ‘B’ glory for Ballyroan-Abbey following six point win over Killeshin WhatsApp Home Deaths Deaths in Laois – Friday, February 7, 2020 Deaths Facebook TAGSDeaths in Laois By Megan Shiel – 7th February 2020 Pinterest Electric Picnic Facebook GAA News WhatsApp RELATED ARTICLESMORE FROM AUTHOR Twitter Pinterest Laois Councillor ‘amazed’ at Electric Picnic decision to apply for later date for 2021 festivallast_img read more

NH-SRCC Children’s Hospital completes 1,000 child heart surgeries

first_img By EH News Bureau on November 18, 2019 News Phoenix Business Consulting invests in telehealth platform Healpha 1,400 children across remote villages of Maharashtra, Goa and Madhya Pradesh were screened, over 33 were found positive with cardiac ailments and over 14.3 per cent patients were treated with cardiac surgeriesNH-SRCC Children’s Hospital, has completed 1,000 child heart surgeries, has redefined holistic paediatric care in India and leverages super-specialist care and new technological developments including the development of newer minimally invasive trans-catheter techniques and ease of availability of high quality surgical and interventional treatment for children detected with congenital heart defects (CHDs).Dr Devi Shetty, Chairman, Narayana Health, said, “Ayushman Bharat will herald a dramatic and significant increase in the number of heart surgeries done especially on children in India. Even after 15 years of successful operation of Yeshasvini, micro health insurance remained predominantly a southern and western Indian phenomenon but with Ayushman Bharat families and children from northern, central and eastern India will also benefit. Narayana Health’s Bengaluru hospitals conduct 12-16 heart operations on children from 76 countries and the only way to reduce cost of heart surgeries is to increase the number of surgeries. We at Narayana Health are investing in technology to digitise healthcare and heart care as well as give patients access to online platforms to induce early diagnostics, treatment and care.”In the last one year, a team of paediatric cardiac specialist doctors screened nearly 1,400 children across remote villages of Maharashtra, Goa and Madhya Pradesh. It was observed that over 33 per cent of children were found positive with cardiac ailments and over 14.3 per cent patients were treated with cardiac surgeries.Dr Soonu Udani, Medical Director, Narayana Health SRCC Children’s Hospital, said, “The hospital conducted series of cardiac care camps across the state of Maharashtra. The hospital has worked very closely with various state governments including Maharashtra, Madhya Pradesh and Goa to reach out to remote villages for free cardiac camps.”Dr Supratim Sen, Senior Consultant Paediatric Cardiologist, Narayana Health SRCC Children’s Hospital, said, “Congenital heart diseases (CHD) account for as much as 28 per cent of all birth defects. The incidence of CHD is around 8-12 per 1000 live births. In India, every year, approximately 240,000 children are born with CHD, of which one-fifth need early intervention to survive the first year of life”.Dr Pradeep Kaushik, Senior Consultant Paediatric Cardiac Surgeon, Narayana Health SRCC Children’s Hospital, said, “Today, due to new technological developments including the development of newer minimally invasive trans-catheter techniques and ease of availability of high quality surgical and interventional treatment, if a child is detected to have a congenital heart defect, the long-term prognosis and future for the patient are excellent.” The missing informal workers in India’s vaccine story Share Comments (0) MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Read Article NH-SRCC Children’s Hospital completes 1,000 child heart surgeries Menopause to become the next game-changer in global femtech solutions industry by 2025 Related Posts Add Comment Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app Ayushman BharatCongenital heart diseasesNH-SRCC Children’s HospitalPaediatric CareYeshasvini WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionalslast_img read more

PM Opens Dry River Bridge

first_imgRelatedPrime Minister Golding Announces Cabinet Changes RelatedPM Opens Dry River Bridge PM Opens Dry River Bridge Office of the Prime MinisterNovember 10, 2011 Advertisements FacebookTwitterWhatsAppEmail KINGSTON — Prime Minister, the Hon. Andrew Holness, on Wednesday (November 9), officially opened the newly re-constructed Dry River Bridge, situated at Harbour View, St. Andrew. The four-lane bridge was constructed by Kier Construction Limited at a cost of approximately US$9 million with funding under the Government of Jamaica (GoJ)/Inter-American Development Bank (IDB) Transportation Infrastructure Rehabilitation Programme. It replaces the previous structure, which was destroyed during the passage of Tropical Storm Gustav in 2008. The bridge project, implemented by the National Works Agency (NWA) over an 18-month period, features raised foot-walks to facilitate pedestrians; energy saving LED street lights and traffic signals; pedestrian crossings; improvements to the Harbour View roundabout; and the installation of 600-mm diameter culvert pipes underground for improved water run offs. Prime Minister Holness, who delivered the main address, said that the work that has been done will “provide a permanent support to the corridor of trade between the eastern end of the island and Kingston.” “I know that you understand and appreciate the value the bridge brings to your lives, community, and the economy, and I therefore encourage you to commute safely on the bridge,” he urged the residents. He further commended them for the “great level” of tolerance and patience while the work was underway and thanked Kier for delivering the project on time and within budget. Transport and Works Minister, Hon. Michael Henry, in adding his commendations, noted that the bridge was the first development implemented by the NWA without the input of overseas consultants, adding that “it’s a proud moment for me”. Similar sentiments were expressed by the NWA Chief Executive Officer, Patrick Wong. IDB Resident Representative in Jamaica, Ancile Brewster, said the Dry River Bridge was one of the many important civil works projects undertaken under the US$50 million Transportation Infrastructure Rehabilitation Project, being financed by the institution.  He said the project aims to rehabilitate essential portions of the island’s main road network, thereby “ensuring physical continuity in the primary transport network”. Additionally, the IDB Representative said the project also aimed to minimise the impact of future flooding; assist in decreasing travel costs for road users; and strengthen and improve the NWA’s capacity to carry out important road, transport and drainage projects”.  Kier Construction’s Richard Havercroft, who was the project manager, said it was with “great satisfaction” that the company was able to deliver on its contract on time and within budget. “In less than a year from the start of …construction, we are here for the opening ceremony today… and it’s very pleasing that we have delivered this job safely and without any report of incident or injury,” Mr. Havercroft added. Other officials and guests participating in the ceremony included: State Minister for Transport and Works, Hon. Othneil Lawrence; and Members of Parliament for East Rural St. Andrew, Joseph Hibbert, and Western St. Thomas, James Robertson. The ceremony was followed by the symbolic ribbon cutting exercise and commissioning of the traffic signals by Prime Minister Holness. By Douglas Mcintosh, JIS Reporter RelatedPM Opens Dry River Bridgelast_img read more

Trump seeks to spring upset in New Mexico next year

first_imgHomeNewsElectionsTrump seeks to spring upset in New Mexico next year Sep. 17, 2019 at 5:25 amElectionsGovernmentNewsPoliticsTrump seeks to spring upset in New Mexico next yearAssociated Press2 years agoDemocratsMichelle Lujan Grishampresidential electionRick GorkaRio Ranchotrump By KEVIN FREKINGAssociated PressPresident Donald Trump headed to New Mexico on Monday for a campaign rally that demonstrates his efforts to capture a few more Democratic-leaning states in next year’s presidential election.Trump’s rally in Rio Rancho, in suburban Albuquerque, will be the first stop on a three-day swing that will also take him to California for fundraisers expected to raise more than $15 million.Trump is looking to find the next Wisconsin or Michigan — states that Democrats generally win in presidential elections but that can surprise under certain conditions, as they did in 2016.New Mexico has not voted for a Republican in the presidential election since 2004. Trump captured just 40% of the state vote in 2016. Hillary Clinton also fell short of a majority victory, with 48% support in a state she did not visit.Still, campaign officials say a Trump rally in nearby El Paso, Texas, last February was well attended by female and Hispanic voters and travelers from New Mexico, indicating to them that New Mexico is in play. Hundreds of people showed up early Monday to claim a place in line ahead of the evening event in Rio Rancho. Protesters, for their part, vowed to step up acts of civil disobedience and demonstrations.“We have the opportunity because of our fundraising and infrastructure to not only defend the states we carried in 2016, but to extend the map in 2020,” said Rick Gorka, a spokesman for a fundraising committee for Trump’s reelection campaign and the Republican National Committee.Gorka said New Mexico is a big part of that strategy, as are Minnesota, New Hampshire and Nevada.Trump’s efforts in New Mexico will provide a test of how well his often-harsh rhetoric about immigrants will play with Hispanic voters, who comprise nearly 40% of New Mexico’s electorate.Trump is likely to cite his efforts to boost oil and gas production in his bid to win over voters. New Mexico is in the midst of an oil-production boom that has boosted employment and spurred a state government spending spree from first-year Democratic Gov. Michelle Lujan Grisham on public education, roadway projects and tax rebates for film productions.Lujan Grisham took aim at Trump ahead of his visit, describing the president as being demeaning to Hispanics and immigrants since being elected. She also said Trump’s policies had resulted in increased taxes for some New Mexicans.Trump will follow up his rally by flying to the San Francisco Bay area on Tuesday for a luncheon fundraiser. He’ll then attend a fundraising dinner that evening in Beverly Hills at the home of real estate developer Geoffrey Palmer. He has two more fundraisers planned in Los Angeles and San Diego on Wednesday.The fundraisers will benefit Trump Victory, the joint entity that funds Trump’s reelection campaign and the Republican National Committee.`Associated Press staff writer Morgan Lee contributed to this report from Santa Fe, New Mexico.Tags :DemocratsMichelle Lujan Grishampresidential electionRick GorkaRio Ranchotrumpshare on Facebookshare on Twitteradd a commentGeorgia couple poses as LA sheriff’s deputies in $16K scamCalifornia asks Trump for housing vouchers to aid homelessYou Might Also LikeFeaturedNewsBobadilla rejects Santa Monica City Manager positionMatthew Hall7 hours agoNewsCouncil picks new City ManagerBrennon Dixson18 hours agoFeaturedNewsProtesting parents and Snapchat remain in disagreement over child protection policiesClara Harter18 hours agoFeaturedNewsDowntown grocery to become mixed use developmenteditor18 hours agoNewsBruised but unbowed, meme stock investors are back for moreAssociated Press18 hours agoNewsWedding boom is on in the US as vendors scramble to keep upAssociated Press18 hours agolast_img

Ericsson, Huawei and NSN team up on OSS

first_img Former Ericsson employees charged in bribery case FCC mulls expanded Huawei, ZTE bans Tags Previous ArticleRBC, Bell Mobility add to payments rivalryNext ArticleAmazon Coins arrive on Kindle Fire Ericsson, Leonardo team on 5G products Related Author Ken Wieland Home Ericsson, Huawei and NSN team up on OSS In a bid to reduce OSS (operations support systems) integration costs – and shorten time-to-market for new service launches – Ericsson, Huawei and Nokia Siemens Networks (NSN) have signed a memorandum of understanding (MoU) to create the “OSS interoperability initiative” (OSSii).Under the terms of the arrangement, the three “initiating parties” have agreed to cross-license their OSS interfaces. They argue this will make life simpler (and cheaper) for operators running multi-vendor networks by enabling interoperability “up front”.The reciprocal agreement covers “fault, performance, configuration and basic network event and trace management for the northbound interfaces from radio access, circuit core and packet core network management systems”.Ericsson, Huawei and NSN – under the terms of the MoU – are committed to bilateral cross-licensing agreements for multi-vendor network management.Cross-licensing and interoperability testing is open for third-party OSS vendors by joining the OSSii.“The OSS marketplace is a patchwork of standards and proprietary interfaces that are controlled by the IPR owners,” said Peter Patomella, head of OSS business at NSN. “With cross-licence agreements, we want to help operators take full advantage of the best available products in our industry.”Thomas Norén, vice president and head of product area radio at Ericsson, said that OSSii would “stimulate innovation in network management” and “cut cost for our customers”.Jiang Wangcheng, president of Huawei’s OSS & service wireless networks business unit, added that the OSSii agreement would “provide operators in all markets the ability to fully capitalise on the best OSS solutions available”. AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 13 MAY 2013 EricssonHuaweiNSNOSSii Ken has been part of the MWC Mobile World Daily editorial team for the last three years, and is now contributing regularly to Mobile World Live. He has been a telecoms journalist for over 15 years, which includes eight…More Read more last_img read more

International Scholarship Programme at National Museum in Berlin

first_img Leave a Reply Cancel ReplyYou must be logged in to post a comment. History Research Associate at Oxford University → ← Call for Papers: “Re-thinking Power and the State in History” in Tampere Share 0 Tweet Reddit Journalism Internship at [email protected], France LinkedIn 0 Similar Stories center_img Pocket International Scholarship Programme at National Museum in Berlin +1 43 EURIAS Humanities and Social Sciences Fellowships Deadline: 31 July 2015Open to: candidates with at least bachelor degreeFellowship: for graduate and/or doctoral candidate 900 Euros/month; for post-doctoral research grants 1,200 Euros/month + allowance for travelling to BerlinDescriptionLaunched in 2009, the International Scholarship Programme offers scholars from around the world the opportunity to spend one to three months on a research residency at the Staatliche Museen zu Berlin. The programme supports research projects that bear direct relation to the diverse institutions and rich collections of the Staatliche Museen zu Berlin. It aims to strengthen the Staatliche Museen zu Berlin’s position within the international scholarly network and is therefore aimed specifically at foreign scholars who do not reside in Germany. The programme especially promotes young researchers. The scholarships allow researchers to work on their project and make professional contacts at the Staatliche Museen zu Berlin. As a result, they also get to participate in the scholarly and cultural life within the Staatliche Museen zu Berlin and Stiftung Preussischer Kulturbesitz.EligibilityThe programme is open for graduate scholars, postgraduates and doctoral candidates as well as post-docs and professors who do not have their residence in Germany. The applicants must hold at least bachelor degree at the time of application.FellowshipAmounts of monthly grants are:Graduate and/or doctoral-candidate grants with a bachelor degree: 900 Euros per month;for post-doctoral research grants holding a doctorate or comparable qualification: 1,200 Euros per month;In addition, a one time allowance for traveling from and to Berlin for up to 500 Euros may be granted upon presentation of the appropriate proofs.How to apply?The application for a grant for 2016 has to be handed in by 31 July 2015. The application has to be submitted directly to the general director of the SMB. The following application documents must be submitted:Completed application form;Tabular CV;Two letters of recommendation from university teachers about the candidate’s academic qualification (only for graduates/doctoral-candidates);List of publications;Copies of college/university diplomas and of certificates indicating the conferral of academic degrees;Detailed exposition of the project with statements concerning the overall aim, method and the preparatory work already achieved.The application shall be send via e-mail to [email protected] or as unbound/untacked papers not later than 31 July 2015 to the following address:Staatliche Museen zu BerlinDer GeneraldirektorStauffenbergstr. 41D – 10785 BerlinFor more information please check the official website. Short Term EVS Project “Decide and Develop” in Croatia April 30, 2015 Published by miro last_img read more